CWP
GILD icon

Cyndeo Wealth Partners’s Gilead Sciences GILD Stock Holding History

Cyndeo Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,824
Closed -$877K – 479
2025
Q1 		$877K Buy
+7,824
New +$807K 0.06% 233

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cyndeo Wealth Partners's GILD Position: Q2 2025 in Review

Cyndeo Wealth Partners sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 7,824 shares — an estimated $877K sold.

Cyndeo Wealth Partners first reported a position in GILD in Q1 2025 and held it in 1 quarter. The position peaked at $877K in Q1 2025. 2,024 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Cyndeo Wealth Partners reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Cyndeo Wealth Partners sold 7,824 Gilead Sciences shares in Q2 2025, an estimated $877K.
  • Cyndeo Wealth Partners first reported a position in Gilead Sciences in Q1 2025 and held it in 1 quarter.
  • Cyndeo Wealth Partners's Gilead Sciences position peaked at $877K in Q1 2025.
  • 2,024 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Cyndeo Wealth Partners's 13F filing for Q2 2025, filed 24 Jul 2025.